Why these 4 ASX shares have tumbled lower today

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has dropped lower despite solid gains from resources shares. At the time of writing the index is down almost 0.4% to 6,242.9 points.

Four shares that have fallen more than most today are listed below. Here’s why they have tumbled lower:

The Ltd (ASX: KGN) share price has fallen a further 11% to $5.21 following the release of its trading update on Tuesday. The ecommerce company’s shares have fallen again despite a broker note out of UBS declaring Kogan’s shares as a buy with a massive $9.55 price target. This price target implies potential upside of over 83% from the current share price.

The Medical Developments International Ltd (ASX: MVP) share price has plunged lower by over 16% to $4.90 after the healthcare company’s U.S. plans for its Penthrox pain management product were dealt a blow. According to today’s release, the U.S. FDA has informed the company that the clinical program for Penthrox is to be put on hold pending a letter outlining outstanding issues and concerns. This letter could take upwards of two months to be received and management will update the market when further information is provided.

The Treasury Wine Estates Ltd (ASX: TWE) share price has dropped 3% to $18.77. Investors have hit the sell button despite the Australian wine industry reporting strong export growth in FY 2018. According to the industry body, courtesy of the SMH, total Australian wine exports jumped 20% to $2.76 billion in FY 2018. This was partly driven by a 55% jump in exports to China. A total of $1.1 billion worth of wine made its way to China during the period.

The Updater Inc (ASX: UPD) share price is down almost 4.5% to $1.20 after the relocation technology company announced a new business vertical. The market appears unimpressed with its fifth vertical – Local Services. This vertical will offer programmatic communication from local businesses to its users and aims to capture a slice of an estimated US$30 billion to US$40 billion that is spent by local businesses on marketing to U.S households.

The ASX small cap up 285% with no sign of stopping...

One Australian company has developed a state of the art device that's revolutionizing hospitals all over the world. Even better, this device is so profitable that the company rakes in 90% margins. That's a lot of cash. So no wonder the stock's up 285% since 2008 – with no signs of stopping...

To discover the name and code, simply click the link below. You'll discover our expert's #1 medical technology pick... and you can decide for yourself whether to get invested today.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ltd and Treasury Wine Estates Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.